mRNA Vaccines and Gene Integration: A New Frontier in Biological Risk, By Mrs. (Dr) Abigail Knight (Florida)
On August 29, 2025, Neo7Bioscience, in collaboration with Dr. Peter A. McCullough and Nicolas Hulscher, MPH, announced a ground-breaking yet alarming discovery: the first direct molecular evidence of synthetic mRNA vaccine genetic material integrating into the human genome. A fragment of the Pfizer BNT162b2 vector was found integrated into chromosome 19 in the tumour of a vaccinated cancer patient. This finding, detailed in a preprint study on Preprints.org, confirms long-standing concerns about the potential for mRNA vaccines to cause genomic instability, challenging the narrative that these vaccines are transient and benign. This essay explores the implications of this discovery, its scientific basis, and the urgent need for further investigation and policy reassessment.
The Discovery: Evidence of Genomic Integration
The Neo7Bioscience study, utilising advanced molecular surveillance techniques, like next-generation sequencing and proteomics, identified a "chimeric fusion read" of synthetic mRNA from the Pfizer BNT162b2 vaccine integrated into human DNA in a cancer patient's tumour. This finding corroborates a 2022 study published in Current Issues in Molecular Biology, which demonstrated that BNT162b2 mRNA can be reverse-transcribed into DNA in human liver cell lines (Huh7) within six hours of exposure, mediated by the LINE-1 retrotransposon. The preprint further highlights plasmid DNA contamination in mRNA vaccine production as a pathway for genomic corruption, introducing foreign DNA that can integrate into host genomes, disrupt cellular programming, and trigger somatic mutations. Posts on X from August 2025, including reports by Nicolas Hulscher, noted persistent mRNA and spike protein in a patient 3.2 years post-vaccination, suggesting long-term molecular dysregulation.
Scientific Implications: A Cascade of Harm
The integration of synthetic mRNA into the human genome has alarming implications:
1.Genomic Instability and Mutagenesis
The integration of foreign DNA, such as plasmid DNA or reverse-transcribed mRNA, can disrupt coding regions, tumour suppressor genes, or regulatory sequences, increasing the risk of mutagenesis. The Neo7Bioscience study notes that even a single integration event can destabilize the genome, potentially leading to cancer or other diseases. A 2023 hypothesis paper warned that activated LINE-1 retrotransposons could drive insertional mutagenesis, a risk amplified by persistent mRNA in cells.
2.Immune Dysregulation
The preprint study on Preprints.org (202507.2155) found widespread transcriptional dysregulation in vaccinated individuals with new-onset adverse events or cancer, including mitochondrial dysfunction, systemic inflammation, and ribosomal errors. Posts on X describe a "cascade of harm" involving thousands of disrupted genes, potentially driving immune dysfunction and chronic inflammation.
3.Long-Term Persistence
Contrary to claims that mRNA vaccines are transient, evidence suggests synthetic mRNA and spike protein can persist for years. Posts on X cite a case where genetic material was detected 3.2 years post-injection, raising questions about chronic health impacts. This persistence could exacerbate autoimmune conditions or cancer progression, as noted in the 2023 hypothesis paper, which linked prolonged mRNA presence to pro-inflammatory responses.
Speculative Motives for mRNA Risks
The motives behind the risks posed by mRNA vaccines are a confluence of systemic factors:
Rushed Development: The urgency to deploy mRNA vaccines during the COVID-19 pandemic, as noted in Nature Reviews Drug Discovery, prioritised speed and scalability over long-term safety studies. This led to inadequate scrutiny of risks, like plasmid DNA contamination or LINE-1-mediated integration.
Overconfidence in Technology: The optimism surrounding mRNA's potential as a revolutionary platform, as highlighted in early 2020 reports, may have downplayed early warnings. The 2022 study's findings of rapid reverse transcription were initially dismissed, reflecting a reluctance to challenge the "safe and effective" narrative.
Commercial and Political Pressures: Financial incentives for pharmaceutical companies and political pressures to restore normalcy during the pandemic likely contributed to regulatory oversights. The preprint notes that plasmid DNA contamination stems from production processes that were not sufficiently vetted.
Conclusion
The Neo7Bioscience findings demand immediate action:
Halt mRNA Platforms: Until comprehensive studies confirm safety, synthetic mRNA vaccines should be paused, as their potential for genomic integration poses unacceptable risks.
Enhanced Surveillance: Platforms like Spike X Detect, combining sequencing and proteomics, are crucial for identifying and mitigating vaccine-related damage.
Personalised Therapeutics: Neo7Bioscience's PBIMA® and REViSS® platforms offer hope for repairing genomic instability through targeted peptide therapies.
Transparency and Accountability: Policymakers must prioritise rigorous, independent research over commercial interests, ensuring public trust in medical interventions.
This discovery underscores the need for caution in deploying novel biotechnologies. By addressing these risks with transparency and scientific rigor, society can mitigate harm and ensure that medical advancements respect human health and dignity. Exactly the opposite occurred during the COVID plandemic.
Comments